Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Rapid Novor Inc. has 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These 2 actions are being handled by 2 distinct examiners, showing that each pending matter is assigned to a different individual. Despite having multiple examiners, the data shows that only 1 distinct art unit is involved, which suggests that the company's current applications are closely related or fall within the same specialized technical category.
HOFFMAN, ALEXANDER JOSEPH is the busiest examiner for the portfolio, with 1 busiest examiner pending office action. Since the total number of pending office actions is 2, this examiner is responsible for a portion of the company's current workload. The presence of 2 distinct examiners indicates a lack of examiner concentration, even though the work remains within 1 distinct art unit. This structure allows for different perspectives from the assigned examiners while maintaining a focus on 1 administrative area of biotechnology and pharmaceuticals.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HOFFMAN, ALEXANDER JOSEPH | 1 | — | — |
| HIBBERT, CATHERINE S | 1 | 58.9% | +48.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18681198 | SYSTEMS AND METHODS FOR ANTIBODY CHAIN PAIRING | HOFFMAN, ALEXANDER JOSEPH | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18009304 | REAGENTS AND METHODS FOR ANTIBODY SEQUENCING | HIBBERT, CATHERINE S | 28d |
| Art Unit | Apps |
|---|---|
| 1658 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18681198 | SYSTEMS AND METHODS FOR ANTIBODY CHAIN PAIRING | HOFFMAN, ALEXANDER JOSEPH | — | §103§112 | Non-Final OA | — | Pending | Feb 05, 2024 |
| 18009304 | REAGENTS AND METHODS FOR ANTIBODY SEQUENCING | HIBBERT, CATHERINE S | 1658 | §112 | Final Rejection | 28d | Pending | Dec 08, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial